Lundbeck’s Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition
Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company ...
Wednesday, April 16, 2025
Tag: Pipeline
Cancer Biotech Repare Therapeutics Restructures to Focus on Clinical-Stage Pipeline
Repare Therapeutics has three cancer drug candidates in the clinic and another one expected to enter Phase 1 by the ...
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.